JPS6399088A - Kbs3-p1002 substance and production thereof - Google Patents
Kbs3-p1002 substance and production thereofInfo
- Publication number
- JPS6399088A JPS6399088A JP61243234A JP24323486A JPS6399088A JP S6399088 A JPS6399088 A JP S6399088A JP 61243234 A JP61243234 A JP 61243234A JP 24323486 A JP24323486 A JP 24323486A JP S6399088 A JPS6399088 A JP S6399088A
- Authority
- JP
- Japan
- Prior art keywords
- substance
- kbs3
- ether
- amino acid
- ash
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は抗真菌活性を有する物質KBS3−P1002
及びその製造法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a substance having antifungal activity, KBS3-P1002.
and its manufacturing method.
本発明者らは、バチルス属菌の生産する抗菌性低分子物
質を探索中バチルス属の一菌株が抗真菌活性物質を生産
することを知り、更に、該物質が新規物質であることを
確認し、これを物質KBS3−P1002と命名し、本
発明を完成するに到った。While searching for antibacterial low-molecular-weight substances produced by bacteria of the genus Bacillus, the present inventors discovered that a strain of the genus Bacillus produces an active antifungal substance, and further confirmed that the substance was a new substance. This was named substance KBS3-P1002, and the present invention was completed.
本発明で使用する菌は物質KBS3−P1002を生産
するものであればいずれでもよいが、例示としてはバチ
ルス(Bacillus) KB−33があげられる。The bacteria used in the present invention may be any species as long as it produces the substance KBS3-P1002, and an example thereof is Bacillus KB-33.
バチルスKB−S3は微工研にFERM P−8986
として寄託されており、また菌学的性質の概要は次の通
りである。Bacillus KB-S3 is FERM P-8986 to Microtech Institute
The mycological properties are summarized as follows.
ダラム染色 十
胞子染色 十
カタラーゼテスト +
オキシダーゼテスト +
物質KBS3−P1002生産菌の培養培地は、資化で
きる炭素源、窒素源、ビタミン等を含有する栄養料等適
宜含有したもので、物質KBS3−P1002を生産蓄
積する培地であればいずれの培地でもよい。Durham staining Decaspore staining Decascatalase test + Oxidase test + The culture medium for the substance KBS3-P1002 producing bacteria contains appropriate nutrients such as assimilable carbon sources, nitrogen sources, vitamins, etc. Any medium may be used as long as it produces and accumulates.
バチルスKB−S3の培養に適した培地は例えば次のも
のがあげられる。Examples of suitable media for culturing Bacillus KB-S3 include the following.
ポリペプトン 30g
酵母エキス 5g
NaC15g
脱イオン水 1111
(pH7,0)
培養は25〜30℃で、通気、撹拌、振どう等好気的に
4日間程度行なわれる。Polypeptone 30g Yeast extract 5g NaC 15g Deionized water 1111 (pH 7,0) Cultivation is carried out aerobically for about 4 days at 25-30°C with aeration, stirring, shaking, etc.
得られた培養液は濾過して濾液を得、これに6N lI
cI2を添加し、PH=3.0に調整し沈澱物を得る。The obtained culture solution was filtered to obtain a filtrate, and 6N lI was added to this.
Add cI2 and adjust the pH to 3.0 to obtain a precipitate.
沈澱物は水に溶解し、NaHCO,を加え、pH=7.
0とし、次いでエタノールを80%まで加える。得られ
た上滑液を真空乾燥し、乾燥物を蒸留水に溶解し。The precipitate was dissolved in water and NaHCO was added to pH=7.
0 and then add ethanol to 80%. The obtained synovial fluid was vacuum dried, and the dried product was dissolved in distilled water.
再び6N H(Jlを加えてpH=3.0に調整し、沈
澱物を得る。得られた沈澱物を蒸留水に溶解し、NaH
COiを加え、 pH=7.0とし、蒸留水に対して透
析する。Add 6N H (Jl) again to adjust the pH to 3.0 to obtain a precipitate. Dissolve the obtained precipitate in distilled water and add NaH
Add COi to pH=7.0 and dialyze against distilled water.
透析内液を凍結乾燥することによって物質KBS3−P
1002含有粗精製物を黄色粉末として得る。The substance KBS3-P was obtained by freeze-drying the dialysate fluid.
A crude product containing 1002 is obtained as a yellow powder.
得られた黄色粉末を水に溶解し、アセトニトリル系で高
速液体クロマトにがけ、これを単離し、凍結乾燥するこ
とによってほぼ純品の物質KBS3−P1002を白色
無定形粉末として得る。The obtained yellow powder is dissolved in water, subjected to high performance liquid chromatography using an acetonitrile system, isolated, and freeze-dried to obtain an almost pure substance KBS3-P1002 as a white amorphous powder.
得られた物質にB53−P4O10の理化学的性質は次
の通りである。The physical and chemical properties of the obtained substance B53-P4O10 are as follows.
1、元素分析値 C:48.27% H: 7.47% N : 11.98% Ash : 1.69% 2、灰化点 183〜185℃ 3、物質の色及び性状:白色粉体 4、紫外線吸収スペクトル:第1図に示す通り。1. Elemental analysis value C: 48.27% H: 7.47% N: 11.98% Ash: 1.69% 2. Ashing point 183-185℃ 3. Color and properties of substance: white powder 4. Ultraviolet absorption spectrum: As shown in Figure 1.
5、赤外線吸収スペクトル:第2図に示す通り。5. Infrared absorption spectrum: As shown in Figure 2.
6、溶剤に対する溶解性:水、メタノール、エタノール
、アセトニトリルに可溶。6. Solubility in solvents: Soluble in water, methanol, ethanol, acetonitrile.
n−プロピルアルコール、アセトン、酢酸エチル、エー
テル、クロロホルム、ジエチルエーテル、石油エーテル
に不溶。Insoluble in n-propyl alcohol, acetone, ethyl acetate, ether, chloroform, diethyl ether, petroleum ether.
7、呈色反応
ニンヒドリンテスト −
8、 アミノ酸組成ニアミノ酸分析機によるアミノ酸組
成は次の通りである。7. Color reaction ninhydrin test - 8. Amino acid composition The amino acid composition determined by an amino acid analyzer is as follows.
9、物質1分゛子あたり構造未決定の脂肪酸が1分子存
在する。9. There is one molecule of undetermined fatty acid molecule per molecule of substance.
10、本物質は真菌に対して強い抗菌性を示す。10. This substance exhibits strong antibacterial properties against fungi.
11、精製法:pH=3.0程度で沈澱させ、沈澱物を
pH=7.0で溶解する工程をくりかえし、最後に高速
液体クロマトにがけることによってほぼ純品を得ること
ができる。高速液体クロマトにおける人220による吸
光度曲線は第3図に示す通りである。矢印が物質KBS
3−P1002を示している。11. Purification method: An almost pure product can be obtained by repeating the steps of precipitating at about pH 3.0, dissolving the precipitate at pH 7.0, and finally applying to high performance liquid chromatography. The absorbance curve of human 220 in high performance liquid chromatography is as shown in FIG. The arrow is the material KBS
3-P1002 is shown.
なお、高速液体クロマトはカラムサイズφ1.0X20
as、ゲルは日立ゲル3053 (シワ力系)、溶出条
件は初発アセトニトリル40%、トリフルオロ酢酸0.
1%の水性溶媒で、最終(40分後)アセトニトリル6
0%、トリフルオロ酢酸、0.1%の水性溶媒になる直
線濃度勾配によって行った。In addition, the column size for high performance liquid chromatography is φ1.0×20
as, the gel is Hitachi Gel 3053 (wrinkle strength type), the elution conditions are initial acetonitrile 40%, trifluoroacetic acid 0.
1% aqueous solvent, final (after 40 min) acetonitrile 6
A linear concentration gradient of 0% trifluoroacetic acid to 0.1% aqueous solvent was performed.
12、抗菌スペクトラム:物質KBS3−P1002の
抗菌 活性は次の表1に示される。12. Antibacterial spectrum: The antibacterial activity of substance KBS3-P1002 is shown in Table 1 below.
表 1 次に本発明の実施例を示す。Table 1 Next, examples of the present invention will be shown.
実施例1゜
バチルスKB−53,FERN P−8986を次の培
地に接種して、27℃で4日間振どう培養した。Example 1 Bacillus KB-53, FERN P-8986 was inoculated into the following medium and cultured with shaking at 27°C for 4 days.
ポリペプトン 30g
酵母エキス 5g
NaCΩ 5g
脱イオン水 lΩ
(PH7,0)
得られた培養液を濾過して、培養濾液とし、これを6N
HCQでptt = 3.0とし、しばらく放置する
と沈澱物が得られるので、得られた沈澱物を蒸留水に溶
解し、これにNaHCO,を加え、 PH=7.0とし
。Polypeptone 30g Yeast extract 5g NaCΩ 5g Deionized water 1Ω (PH7,0) The obtained culture solution was filtered to obtain a culture filtrate, which was diluted with 6N
Adjust ptt to 3.0 with HCQ and leave for a while to obtain a precipitate. Dissolve the obtained precipitate in distilled water, add NaHCO, and adjust the pH to 7.0.
更にエタノールを80%まで加え、濾過する。得られた
上清を真空乾燥し、乾固物を得る。この乾固物を蒸留水
に溶解し、6N HCfiでpH=3.0とし、しばら
く放置し、沈澱物を得る。この沈澱物を蒸留水に溶解し
、NaHCO3でptt = 7.0とし、この溶液を
蒸留水に対して透析する。Further add ethanol to 80% and filter. The obtained supernatant is vacuum dried to obtain a dried product. This dried product is dissolved in distilled water, adjusted to pH=3.0 with 6N HCfi, and left to stand for a while to obtain a precipitate. This precipitate is dissolved in distilled water, brought to ptt = 7.0 with NaHCO3, and the solution is dialyzed against distilled water.
得られた透析液を凍結乾燥し、物質KBS3−P100
2含有の粗精製物を黄色粉末で得る。The obtained dialysate was lyophilized and the substance KBS3-P100
A crude product containing 2 was obtained as a yellow powder.
得られた黄色粉末を高速液体クロマトにかけ、第3図に
矢印で示す物質KBS3−PIO02該当部分をとり、
これを凍結乾燥することにより、はぼ純品の物質KBS
3−PIO02を白色無定形粉末として得た。The obtained yellow powder was subjected to high-performance liquid chromatography, and the corresponding part of the substance KBS3-PIO02 indicated by the arrow in Fig. 3 was taken.
By freeze-drying this, Habo pure substance KBS
3-PIO02 was obtained as a white amorphous powder.
第1図は物質に853−P4O10の紫外線吸収スペク
トルを示す図で、第2図は同じく赤外線吸収スペクトル
を示す図で、第3図は物質KBS3−P1002含有粗
精製物の高速液体クロマトによる人220による吸光度
曲線を示す図である。矢印は物質KBS3−P1002
を示す。Figure 1 is a diagram showing the ultraviolet absorption spectrum of the substance 853-P4O10, Figure 2 is a diagram showing the infrared absorption spectrum, and Figure 3 is a diagram showing the infrared absorption spectrum of the substance KBS3-P1002 as measured by high performance liquid chromatography. It is a figure showing the absorbance curve by. The arrow indicates the substance KBS3-P1002
shows.
Claims (2)
002。 1、元素分析値 C:48.27% H:7.47% N:11.98% Ash:1.69% 2、灰化点 183〜185℃ 3、物質の色及び性状:白色粉体 4、紫外線吸収スペクトル:第1図に示す通り。 5、赤外線吸収スペクトル:第2図に示す通り。 6、溶剤に対する溶解性:水、メタノール、エタノール
、アセトニトリルに可溶。 n−プロピルアルコール、アセトン、酢酸 エチル、エーテル、クロロホルム、ジエチ ルエーテル、石油エーテルに不溶。 7、呈色反応 ニンヒドリンテスト 8、アミノ酸組成:アミノ酸分析機によるアミノ酸組成
は次の通りである。 9、物質1分子あたり構造未決定の脂肪酸が1分子存在
する。(1) Substance KBS3-P1 with the following physical and chemical properties
002. 1. Elemental analysis value C: 48.27% H: 7.47% N: 11.98% Ash: 1.69% 2. Ashing point 183-185°C 3. Color and properties of substance: White powder 4 , UV absorption spectrum: as shown in FIG. 5. Infrared absorption spectrum: As shown in Figure 2. 6. Solubility in solvents: Soluble in water, methanol, ethanol, acetonitrile. Insoluble in n-propyl alcohol, acetone, ethyl acetate, ether, chloroform, diethyl ether, petroleum ether. 7. Color reaction ninhydrin test 8. Amino acid composition: The amino acid composition determined by an amino acid analyzer is as follows. 9. There is one molecule of undetermined fatty acid molecule per molecule of substance.
産菌を培養し、物質KBS3−P1002を採取するこ
とを特徴とする物質KBS3−P1002の製造法。(2) A method for producing the substance KBS3-P1002, which comprises culturing a substance KBS3-P1002-producing bacteria belonging to the genus Bacillus and collecting the substance KBS3-P1002.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61243234A JPS6399088A (en) | 1986-10-15 | 1986-10-15 | Kbs3-p1002 substance and production thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61243234A JPS6399088A (en) | 1986-10-15 | 1986-10-15 | Kbs3-p1002 substance and production thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6399088A true JPS6399088A (en) | 1988-04-30 |
| JPH0378878B2 JPH0378878B2 (en) | 1991-12-17 |
Family
ID=17100829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61243234A Granted JPS6399088A (en) | 1986-10-15 | 1986-10-15 | Kbs3-p1002 substance and production thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6399088A (en) |
-
1986
- 1986-10-15 JP JP61243234A patent/JPS6399088A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0378878B2 (en) | 1991-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4261979A (en) | Novel water-soluble compounds derived from extracts of streptomyces stimulosus, process for their production, their uses as immunological adjuvants and compositions containing them | |
| JPS6399084A (en) | Kbs1-p107 substance and production thereof | |
| JPS6399087A (en) | Kbs2-p104 substance and production thereof | |
| JPS6399089A (en) | Kbs3-p1003 substance and production thereof | |
| US4177108A (en) | Process for producing emitanin | |
| JPS6399085A (en) | Kbs2-p102 substance and production thereof | |
| EP0491114A1 (en) | A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity | |
| JPS6399086A (en) | Kbs2-p103 substance and production thereof | |
| JPS6399090A (en) | Kbs3-p1004 substance and production thereof | |
| JPH0378878B2 (en) | ||
| JPS6327484A (en) | Bisucaberin and production thereof | |
| JPS625990A (en) | Antibiotic substance and production thereof | |
| JPS62135496A (en) | P3 substance and preparation thereof | |
| JPS62135497A (en) | P4 substance and preparation thereof | |
| US3089816A (en) | Lemacidine and process for its manufacture | |
| JPS62135498A (en) | 30-2 substance and preparation thereof | |
| US3297526A (en) | Process for producing coprogen and desferricoprogen | |
| JPS62135494A (en) | P19 substance and preparation thereof | |
| JPS62135495A (en) | P2 substance and preparation thereof | |
| JP3029331B2 (en) | Animal cell growth promoter | |
| JPS6030689A (en) | Physiologically active substance spf-1 and its preparation | |
| EP0024206A2 (en) | Antitumor substance, composition comprising it and process for preparing said substance | |
| JPS61130250A (en) | Antibiotic caf-0603 | |
| JPS606197B2 (en) | Method for producing microbial flocculant using Corynebacterium spp. | |
| JPS6287521A (en) | Antitumor substance spf-100-fii and production thereof |